In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
Did you know that your browser is out of date? To get the best experience using our website we recommend that you upgrade to a newer version. Learn more.

We use cookies to optimise the design of this website and make continuous improvement. By continuing your visit, you consent to the use of cookies. Learn more

Risk assessment in the asymptomatic patient

Session presentations
Non-Invasive Imaging

This was a session on a clinically relevant and also controversial topic with excellent presentations and a vivid discussion.

Calcium scoring
Prof. Knuuti gave a review of the currently available data, as well as on the current recommendations and guidelines. Especially, in intermediate risk patients, a coronary calcium scan might be considered to furthermore estimate an individual’s risk. But only, if diagnostics is potentially followed by a therapy.

Nuclear imaging
Prof. Zellweger  gave an overview on nuclear imaging. He highlighted the difference of morphologic and functional imaging. Which must be considered not oppositional, but additive.
Nuclear imaging might be useful in asymptomatic high risk patients, e.g. diabetics.

Computed tomography angiography
Dr.Scholte started his presentation with the statement “There is non indication for CTA in asymptomatic patients”. According to the current recommendations, a CTA  might be considered in symptomatic patients with intermediate pre-test probability of having a significant lesion. However, Dr. Scholte showed some clinical cases, e.g. after radiation because of M.Hodgkin, underlining that a CTA might be also useful in very selected cases.

Cardiac magnetic resonance
Prof.Schwitter gave an overview of the potential of CMTR in asymptomatic patients, focusing not only on CAD, but also on HCM or ARVD. He showed a review of the relevant literature, especially also on the prognostic value of CMR to predict the probability of developing an acute myocardial infarction in the future. In the absence of any ischemia, the prognosis is excellent.

Concluding, this was, all in all, an excellent session, not resolving all the open issues in this context, but giving a very good overview on the potential of the different techniques. The most important point, apart from the accurate patient selection, remains of course the appropriate expertise when using these modalities.




Risk assessment in the asymptomatic patient

The content of this article reflects the personal opinion of the author/s and is not necessarily the official position of the European Society of Cardiology.